Shah Pratik Insider Trades

Insider Trading History

Track insider trading activity for Shah Pratik. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $228k 30,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 30,000 shares
$10.54
$7.61
Design Therapeutics
Design Therapeutics DSGN
President, CEO And Chairperson
Holding Value $10.1M 750,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.83M 750,000 shares
$9.10
$13.52
Design Therapeutics
Design Therapeutics DSGN
President, CEO And Chairperson
Holding Value $7.1M 525,000 shares
Last Trade
Dec 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.87M 525,000 shares
$9.27
$13.52
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $34.8M 4,574,554 shares
Last Trade
Nov 12, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$3.13M 350,000 shares
$8.94
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $228k 30,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 30,000 shares
$17.26
$7.61
Design Therapeutics
Design Therapeutics DSGN
President, CEO And Chairperson
Holding Value $8.11M 600,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.7M 600,000 shares
$6.17
$13.52
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $304k 40,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 40,000 shares
$7.73
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $36.7M 4,824,554 shares
Last Trade
Jun 07, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.7M 1,332,950 shares
$8.81
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $10.1M 1,332,900 shares
Last Trade
Jun 04, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.9M 1,332,900 shares
$8.94
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $57M 7,490,404 shares
Last Trade
Jun 04, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$23.8M 2,665,800 shares
$8.94
$7.61
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $46.9M 6,157,504 shares
Last Trade
Jun 04, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.9M 1,332,900 shares
$8.94
$7.61
Design Therapeutics
Design Therapeutics DSGN
President, CEO And Chairperson
Holding Value $14.2M 1,050,000 shares
Last Trade
Sep 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.91M 1,575,000 shares
$2.48
$13.52
Silverback Therapeutics
Silverback Therapeutics SBTX
10% owner
Holding Value $235k 40,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 40,000 shares
$5.87
$5.87
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
10% owner
Holding Value $304k 40,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 40,000 shares
$6.50
$7.61
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $5.61M 415,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.31M 415,000 shares
$7.97
$13.52
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $6.42M 475,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.07M 475,000 shares
$12.77
$13.52
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $0 0 shares
Last Trade
Mar 30, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$5.05M 171,025 shares
$29.52
$13.52
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $1.76M 129,923 shares
Last Trade
Mar 30, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6.19M 209,846 shares
$29.52
$13.52
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $338k 25,000 shares
Last Trade
Mar 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$738k 25,000 shares
$29.52
$13.52
Design Therapeutics
Design Therapeutics DSGN
Executive Chairperson
Holding Value $0 0 shares
Last Trade
Mar 25, 2021 Sale
No data
No data
$13.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up